Introduction
Botrytis cinerea is the causal agent of grey mould disease, which affects more than 200 agriculturally important and ornamental plant species. This necrotrophic fungus is able to kill host cells through the production of toxins and reactive oxygen species and by inducing a plant-produced oxidative burst. [1, 2] Two groups of nonspecific phytotoxins have been identified: the botryanes [3] and the botcinins (1) (2) (3) . [4] In addition, a new polyketide metabolite family, the botrylactones (4), whose phytotoxic activity has not yet been evaluated, has been identified.
[5] Botcinins (1-3) and botrylactones (4) are related polyketides sharing an identical C1-C8 fragment (Scheme 1). Currently, metabolites of the botcinin family are of particular interest because of their phytotoxicity and antifungal activity against the fungus Magnaporthe grisea, the causal agent of rice blast.
[4] Furthermore, a synergistic behaviour of botcinin and botryane toxins in the phytotoxicity and infection mechanism of the phytopathogen B. cinerea has been reported, [6] and two new potential biological targets for the control of this phytopathogen have been revealed. Consequently, there is great interest in ascertaining the mode of action of these molecules and their biosynthetic pathways.
Preliminary studies in which sodium [ (2) to be an acetate-derived polyketide; it is assembled from C-8 to C-1, with its four pendent methyl groups originating from the methyl group of methionine (Scheme 2). [7, 8] Incorporation of methyl groups from methionine by a methyltransferase domain is often observed in fungal iterative type I polyketide synthases (PKSs). Unusually though, in this system we observed an apparent three-carbon starter unit derived from acetate and methionine. To the best of our knowledge, an acetate/methionine-derived C 3 starter unit has only been observed in a small handful of metabolites. [9] [10] [11] [12] We recently published a revised structure and absolute configuration of botrylactone, thereby demonstrating that derivatives of botcinin (1-3) and botrylactone (4) share the same functional groups and stereochemistry, and differ only by one acetate unit. This finding led us to propose a common biosynthetic origin.
[5c] In this paper, we confirm this on the basis of 
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isotopic labelling experiments and the functional analysis of B. cinerea mutants that are impaired in the production of some compounds and overproduce others. [13] Results and Discussion
The PKS genes responsible for botcinic acid (3 a) production have recently been investigated by using transcriptomic and reverse genetic approaches. Inactivation of the genes BcBOA6 and BcBOA9 (formerly named BcPKS6 and BcPKS9) indicated that they act in concert to synthesise 3 a. [13] Indeed, the study of mycelium cultures by the previously described methodology [6, 7] indicated that the bcboa6D and bcboa9D null mutants do not produce 3 a or its derivatives. Additionally, no botrylactone (4) was detected in the growth filtrate of the bcboa6D mutant, whereas this compound was shown to be overproduced by the bcboa9D mutant. [13] Taken together, these data suggested that BcBOA6 is required for the production of both 3 a and 4. Bioinformatics study of both BcBOA6 and BcBOA9 enzymes predicted the three essential PKS domains, that is, the ketoacyl synthase (KS), acyl transferase (AT) and acyl carrier protein (ACP) domains. Interestingly, additional domains were also predicted: dehydratase (DH), ketoreductase (KR), methyl transferase (MT) and enoyl reductase (ER) domains. Although DH and KR domains were found in both PKS enzymes, the MT domain is present in BcBOA6 only, and the ER domain is present in BcBOA9. [13] The MT domain could be responsible for the incorporation four methyl groups.
It is likely then that BcBOA6 mediates the formation of the per-methylated tetraketide core, common to both 4 and the botcinins (1), whereas BcBOA9 is likely to be responsible for the 7-O-acyl tetraketide side chain of botcinic acid and its derivatives (1-3). This assembly would be analogous to that by the two PKSs in lovastatin biosynthesis, in which one PKS makes the carbon skeleton and a second is involved in furnishing the O-acyl side chain.
[14] The pathways to botrylactone (4) and botcinins (1) are likely to diverge, with a botrylactone-like precursor (5) opening up through a retro-Claisen mechanism to afford botcinins and derivatives (1-3; Scheme 2).
In order to investigate this hypothesis, feeding experiments with sodium [1- C]acetate was fed to a bcboa9D culture, significant enrichment was observed at C-1, C-3, C-5, C-7 and C-9. Feeding experiments with sodium [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]acetate and with a mixture of sodium [2- 13 C]malonate and unlabelled sodium acetate led to enhanced signals that corresponded to C-2, C-4, C-6 and C-8 in both experiments. Further signal enhancement corresponding to the C-10 methyl group was observed in the experiment with [2- 13 C]acetate. The 13 C NMR spectrum of 4 derived from sodium [1,2-13 C 2 ]acetate exhibited 13 C, 13 C spin-spin coupling for all the carbons with the exception of the methyl groups at C-2, C-4, C-6 and C-8. The measured J CC values are given in Table 1 and prove the presence of the following intact acetate units: C-1/C-2, C-3/C-4, C-5/C-6, C-7/C-8 and C-9/C-10. These results clearly reveal the origin of 10 of the 14 carbon atoms in botrylactone (4): units C-1/C-2, C-3/C-4, C-5/C-6, and C-7/C-8 come from acetate units via malonate, whereas the C-9/C-10 fragment is derived directly from acetate.
The next step was to establish the origins of the remaining four carbons of 4. If botrylactones and botcinins have a common biosynthetic origin, these four carbon atoms would be derived from the methyl group of methionine. The 2 H NMR of 4 isolated from a feeding experiment with l-[ 2 H 3 -methyl]methionine showed four singlets at d = 1.40, 1.12, 1.12 and 1.03 ppm, attributable to methyl groups at C-2, C-4, C-6 and C-8, respectively. This confirms that the methyl group at C-9 arises from the C-2 of acetate and that the extra methyl groups come from the methyl group of methionine.
All these data are consistent with our hypothesis. B. cinerea biosynthesises a C 10 -polyketide by condensation of four units of malonyl-SCoA with one unit of acetyl-SCoA, which would be methylated in activated methylene groups to yield 5. This putative bicyclic acid intermediate (5) could then either be converted to botrylactone (4) derivatives or lose the starter acetate unit through a retro-Claisen type CÀC bond cleavage to yield botcinin derivatives (1-3; Scheme 2). 13 C-labelled malonate can be used to detect lack of polyketide acetate starter, because a significantly lower degree of labelling of acetate starter unit carbon atoms would be observed when this unit is present. Feeding of sodium [2- 13 C]-malonate, administered in a mixture with unlabelled sodium acetate, was used to demonstrate the loss of starter unit in the biosynthesis of aurovertins. [15] In order to determine whether the acetate starter unit is present in botcinins and derivatives (1-3), a feeding experiment with sodium [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]malonate and unlabelled sodium acetate was performed with the strain bcbot2D. This mutant, obtained by inactivation of the botryanes biosynthesis gene BcBOT2 (encoding a sesquiterpene cyclase) is unable to produce botryanes (major metabolites of B. cinerea) but is capable of producing elevated amounts of botcinins (1-3). [16] The 13 C NMR spectra of the resulting isolated botcinins (1) showed clear enhancement of the signals corresponding to C-2, C-4, C-6, C-8, C-2', C-4' and C-6' for both compounds (Table 2 , Scheme 2) and further enhancement of the signal corresponding to C-8' for botcinin B (1 b). All carbons were labelled to the same degree. The signals corresponding to the acetyl group (CH 3 CO) and the starter unit of the side chain (C-8' for botcinin A (1 a) and C-10' for botcinin B (1 b)) did not exhibit any enhancement. Thus a clear "acetate starter" effect is observed, thus indicating that the side chain on C-7 is formed from a single polyketide chain. [a] Atom % 13 C excess = {(R N /R N(UL) 1.1}À1.1, where R N is the ratio of the peak intensity at the N-position in labelled compound calculated on the basis of the peak intensity at the 2-CH 3 -position. Similarly, R N(UL) is the ratio of the peak intensity at position N in unlabelled compound. Value 1.1 is the theoretical 13 C natural abundance (atom %). [a] Atom % 13 C excess = {(R N /R N(UL) 1.1}À1.1, where R N is the ratio of the peak intensity at the N-position in labelled compound calculated on the basis of the peak intensity at the 2-CH 3 position. Similarly, R N(UL) is the ratio of the peak intensity at position N in unlabelled compound. Value 1.1 is the theoretical 13 C natural abundance (atom %). The enhancement observed at C-8, similar to that for the carbons proceeding from malonate, and the absence of label in the 3-O-acetyl group point to the biosynthetic pathway outlined in Scheme 2, where the botrylactone precursor 5 is turned into 3-O-acetylbotcineric acid (2) through a retro-Claisen type reaction.
A further feeding experiment with sodium [ 2 H 3 ]acetate was conducted to obtain additional evidence in support of this hypothesis. The incorporation of this labelled precursor into botcinins through the postulated bicyclic acid intermediate 5 (Scheme 2) should result in the total loss of deuterium atoms at C-8.
Sodium [ 2 H 3 ]acetate was pulse fed twice to the bcbot2D mutant, and the resultant botcinins (1) were analysed by 2 H NMR. Although a low degree of incorporation was observed, signals assigned to 2 H atoms on C-2', C-2, C-6' and C-8', and on the methyl acetate group at C-3 were unambiguously identified for both botcinins. A further signal corresponding to 
Conclusions
The isotopic labelling experiments reported here, together with the results obtained with the B. cinerea mutants bcbot2D and bcboa9D, enable us to propose and confirm the biosynthetic route outlined in Scheme 2: sequential assembly of a pentaketide (C 10 ) based on an acetate primer unit leading to botrylactones (4) or to botcinins (1) (2) (3) . This biosynthetic route clarifies the origin of the starter unit in botcinins (1-3); this unit arises from acetate and it is lost through a retro-Claisen type CÀC bond cleavage of a botrylactone-like precursor (5). It is highly likely that the 3-O-acetyl group in botcinins (1, 2, 3 b) is derived from the acetate starter unit of the botrylactone-like precursor (5).
Two polyketide synthases BcBOA6 and BcBOA9 [13] are involved in the biosynthesis of botcinins. BcBOA6 mediates the formation of the per-methylated tetraketide core, common to both botrylactone (4) and the botcinin derivatives (1-3), whilst BcBOA9 is probably required for the biosynthesis of the tetraketide side chain of botcinic acid (3 a). Our scenario has similarities to the well-described biosynthesis of lovastatin in Aspergillus terreus.
[14]
The BcBOA6 and BcBOA9 genes are two of 17 BcBOA genes, separated into two different gene clusters: cluster A (BcBOA1 to BcBOA6) and cluster B (BcBOA7 to BcBOA17); all are putatively involved in botcinic acid (3 a) biosynthesis. [13] BcBOA5 encodes an ER that might take over the ER function of BcBOA6, as described for other fungal polyketides. [14, 17, 18] BcBOA2, BcBOA3, BcBOA4 and BcBOA7 encode P450 monooxygenases. BcBOA2, BcBOA3 and BcBOA4 might be involved in further hydroxylations at C4, C5 and C8, whereas BcBOA7, close to BcBOA9, could potentially be involved in the hydroxylation at C4 in the side chain of botcinins (1-3). , MA) . All samples were dissolved in water and sterilised through 0.22 mm Millex GP filters (Millipore) before being added to the fermentation bottles. Malonic acid was dissolved in water, neutralised with NaOH (1 n) and filter-sterilised.
Experimental Section
Microorganisms: B. cinerea mutants, bcbot2D and bcboa9D, were previously obtained by inactivation of the genes encoding the sesquiterpene synthase BcBOT2 [15] and the polyketide synthase BcBOA9 (BcPKS9), [13] respectively, and are maintained in the BIOGER strain collection, INRA (Grignon, France). Conidial stock suspensions of these strains were maintained in glycerol (80 %) at À40 8C.
Feeding experiments of labelled precursors; extraction and isolation of polyketides 6 fresh conidia or six uniform discs of 0.9 cm diameter mycelial of a five-day-old culture on malt agar. A filter-sterilised aqueous solution of the labelled precursor was fed as a pulse at the precisely determined optimum time. Roux bottles were incubated at 25 AE 2 8C in daylight under static conditions for the optimum period of time to isolate the polyketide toxins. After this, the culture medium and mycelia were separated by filtration. The broth was saturated with NaCl and extracted with ethyl acetate (3 ). The organic extract was washed with distilled water (3 ) and dried over anhydrous Na 2 SO 4 . The organic extract obtained was evaporated at reduced pressure to dryness. A (1 a) and B (1 b) . The extract was dissolved in CHCl 3 and stirred with drops of HCl (35 %) for 5-7 days to achieve lactonisation of 3-O-acetylbotcinic acid (3 b) and 3-O-acetylbotcineric acid (2) to botcinins A (1 a) and B (1 b), respectively. The crude extract was passed through silica gel partition column chromatography with n-hexane/ethyl acetate (65:35; 300 mL) as eluent. This fraction was purified by normal phase HPLC with a LiChrospher Si 60 (10 mm) LiChroCART (250 mm 10 mm) column and n-hexane/ ethyl acetate (70:30) as mobile phase, to yield fractions 1 and 2 (t r %29 and 35 min, respectively). Fractions 1 and 2 were purified with a LiChrospher Si 60 (5 mm) LiChroCART (250 mm 4 mm) and n-hexane/ethyl acetate (80:20) as mobile phase, to yield compounds 1 (t r % 42 and 55 min, respectively).
Isolation of botcinins
Isolation of botrylactone (4). The extracts were subjected to column chromatography on silica gel with an increasing gradient of ethyl acetate in n-hexane as eluent. Final purification was carried out by normal phase HPLC in a LiChrospher Si 60 (10 mm) LiChroCART
